. . . . . . . . . . . "a(CHEBI:wortmannin) -| r(HGNC:CA9)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "The PI3K inhibitors LY294002 and wortmannin inhibited CAIX expression in dense cultures in a dose-dependent manner, specifically targeting the CA9 promoter (-173/+31 region) that was transactivated by constitutively active p110 PI3K subunit." . . "Selventa" . . . . "2014-07-03T14:30:04.887+02:00"^^ . . .